Who We Are?

Transforming Smart Inventions Into Smart Investments

Every day, thousands of health care professionals treat and care for patients within Clalit Health Services’ huge network. By the bedside, at diagnostic clinics, in ORs and ERs, and community medical centers, they save and improve the quality of life of over 5 million members.

Along the way, they also see and feel the pain, suffering, and discomfort patients often must endure. A desire to help combined with deep knowledge, resourcefulness and creativity sometimes result in discoveries and smart ideas with great commercial potential.
Through its end-to-end technology transfer services, Mor Research Applications helps inventors translate new ideas in the medical devices, pharmaceutical, diagnostics, digital healthcare, and biotech areas into products and solutions that benefit healthcare providers and patients.

At any given time we have over 100 projects at various stages of development, from pre-seed and up to spin-off. We work to maximize the potential of the idea by securing the rights to the intellectual property, bringing on the right partners, and promoting these smart investments. We facilitate cooperation of our physicians with academic institutions or companies that can turn their ideas into products and technologies.

100

Projects & Companies

700M

Investment in our Companies

Years of Experience

Since its establishment in 1994, Mor Research Applications has been the Technology Transfer Office of Clalit Health Services, Israel’s largest HMO. Over two decades of experience ensure that the process of commercialization of these inventions yields gains for their researchers, industry partners, investors, and the public at large.

Mor’s role starts from the initial inventor’s idea review, patent, raising early funding, and taking it to the stage where it is ready to be commercialized.

Mor Research Application serves professionals working at all fourteen hospitals owned by Clalit (Rabin (Beilinson and HaSharon), Meir, Kaplan, Carmel, Soroka, Ha-Emek, Yossef Tal, Schneider, Geha, Beit Rivka, Harztfeld, Beit Levinshtein, Shalvata) Medical Centers, and around 2,000 community clinics across Israel. Mor’s team of professionals work together with the various hospitals to promote innovation by the staff and provide the support they need.

MOR draws on over two decades of experience to ensure that the process of commercialization of these inventions yields gains for the researchers, industry partners, and the public at large.

The main role of MOR Research Application is to capture innovation through its invention disclosure process

evaluate whether the invention has market and patent protection value, secure patent protection, secure licensing agreements or establish spin-offs for further development. In addition to the IP department, MOR serves Clalit’s employees through its research fund division, which currently handles over one thousand funds for Clalit doctors and researchers. Mor was founded in 1994 as a subsidiary of The Mor Institute and a holding of Clalit Health Services.

The Team

Led By A Strong And Executive Management Team

Shay Marcus

Chief Executive Officer

Lena Shot

Chief Finance Officer

Sari Prutchi Sagiv Phd

Tech Transfer Director, Pharma And Diagnostics

Allen Richter

Ip Manager, Medical Devices

Avital Pritz

Director Tech Transfer, Medical Devices And Digital Health

Amitai Shapira

General Counsel

Dr. Prutchi-Sagiv brings Mor over 20 years of proven management experience. She has led scientific, regulatory, business development and marketing strategies in life science projects from seed and early stage through capital raising and partnership with top tier strategic investors. Dr. Prutchi Sagiv studied Business Administration at Tel Aviv University and holds an M.Sc. in Human Genetics and a Ph.D. in Cell Biology and Immunology from the same University. She acts as a member of the Board of Directors at Bonfix.

Contact Mor Research

You welcome to get in touch with us or leave us your details and we will come back to you as soon as possible.